SP Group (SPG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
25 Aug, 2026Executive summary
Achieved record Q1 2026 results with revenue up 22.9% year-over-year to DKK 966 million and EBITDA up 18.5% to DKK 197 million, driven by strong organic growth and expansion in proprietary products and subcontracting tasks.
Growth supported by both organic expansion (11.3%) and the acquisition of Idé-Pro (11.6%), with integration progressing as planned and supporting cross-selling and international expansion.
High activity levels and strong inflow of new customers, especially in Healthcare.
Continued investments in healthcare production capacity, especially in Poland.
Launched new solar park in Denmark, supporting sustainability initiatives.
Financial highlights
Revenue increased by 22.9% year-over-year to DKK 966 million, with organic growth of 11.3%.
EBITDA rose by 18.5% to DKK 197 million, with a margin of 20.4%.
EBIT grew by 19.1% to DKK 140 million; EBT up 24.2% to DKK 126 million.
Diluted EPS increased by 28.6% to DKK 8.4.
Operating cash flow improved by DKK 28 million to DKK 159 million.
Net interest-bearing debt reduced by DKK 72 million to DKK 1,388 million.
Outlook and guidance
2026 guidance maintained: revenue growth of 15–23% (DKK 3.4–3.6 billion), EBITDA margin of 19–21%, EBT margin of 11–13%.
Growth expected from new products, new customers, and the addition of Idé-Pro, which is expected to contribute about 15% of full-year revenue.
High activity and capacity utilization expected to continue, with growth dependent on normalization of geopolitical conditions.
Latest events from SP Group
- Record H1 2026 growth and UK expansion led to upgraded outlook and strong margins.SPG
Q2 2026 - Record H1 2026 revenue and earnings growth led to an upgraded full-year outlook.SPG
Q2 2026 - Record Q1 2026 growth, robust outlook, and active capital returns amid global uncertainty.SPG
Q1 2026 - Record Q4 and strong 2026 growth outlook, boosted by Idé-Pro acquisition.SPG
Q4 2025 - Record Q4 and Idé-Pro acquisition set stage for strong 2026 growth amid ongoing uncertainties.SPG
Q4 2025 - H1 2025 saw lower revenue and earnings, but margin guidance and growth projects remain on track.SPG
Q2 2025 - Strong H1 2024 growth, upgraded outlook, and international expansion led by healthcare sales.SPG
Q2 2024 - Q1 2025 delivered 8.8% revenue growth and margin expansion, with outlook unchanged.SPG
Q1 2025 - Record revenue and margin growth in 2024; cautious 2025 outlook with focus on own products.SPG
Q4 2024